Previous 10 | Next 10 |
Business Wire news releases related Business Wire news releases and Business Wire press releases from 02/25/21 07:00:00 on US and Canada Markets.
CTP-543 Phase 3 Program Advancing in Alopecia Areata; THRIVE-AA2, the Second CTP‑543 Phase 3 Trial, to Initiate 1H2021 CTP-543 Long-Term Data Presented at EADV Show Hair Regrowth was Maintained or Improved in Patients with Alopecia Areata, Expanding Previous Phase...
NIC Inc. Chief Executive Officer and Chairman of the Board Harry Herington was honored by CEO Today Magazine with a 2021 CEO Global award, recognizing the strong and innovative leadership amongst the most inspiring CEOs and business leaders across the globe. CEO Today ...
Pioneering autonomous safety-enhancing technology recognized for collaborative innovation Garmin ® International, Inc., a unit of Garmin Ltd. (NASDAQ: GRMN), today announced that its revolutionary Garmin Autoland system was honored by FLYING Magazine with a 20...
2021 Vaccine Manufacturing: Raises lower end of global manufacturing plan for 2021 from 600 million doses to 700 million doses; manufacturing is still working to supply up to 1 billion doses for 2021 2022 Vaccine Manufacturing: Based on the high demand from...
-- Launched EYSUVIS™, First and Only Prescription Therapy Approved Specifically for Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease -- -- Progressing Pipeline Programs to Address Front and Back of Eye Diseases -- -- Cash Position and INVELTYS R...
— Achieved Favorable Clinical Results Across Four First-in-Class Gene Therapy Programs for Danon Disease, FA, LAD-I and PKD — — Announced >50% Protein Expression with Stabilization and Biomarker Improvement Including Cardiac Output in Lo...
EVO Payments, Inc. (NASDAQ: EVOP) (“EVO” or the “Company”) today announced its fourth quarter and year-end 2020 financial results. For the fourth quarter ended December 31, 2020, reported revenue was $116.7 million compared to $129.4 million in the prior year...
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that members of its senior management team are scheduled to participate in three upcoming virtual investor conferences. ...
CONSOLIDATED HIGHLIGHTS Fourth Quarter 2020 Total revenue increased 10.3% to $2,123 million Property revenue increased 10.0% to $2,100 million Net income decreased 36.5% to $362 million Adjusted EBITDA increased 13.0% to $1,375 million Consolidated AFFO...
The GEO Group, Inc. (NYSE: GEO) (“GEO” or the “Company”) announced today that its wholly-owned subsidiary, GEO Corrections Holdings, Inc. (“GEOCH”), has closed its previously announced private offering of $230,000,000 aggregate principal amo...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
44.51%Change Percent:
Virios Therapeutics Inc. Company Name:
VIRI Stock Symbol:
NASDAQ Market: